Wilson Greatbatch, co-inventor of the ﬁrst successful implanted pacemaker, founded Greatbatch, Inc. in 1970 to develop long-lived primary batteries to fuel pacemakers. His passion for reliability and innovation is the foundation for Greatbatch’s full portfolio of capabilities and offerings. We manufacture to customer and best-practice speciﬁcations. We deliver comprehensive consulting expertise and assembly services. Every day, Greatbatch supports and empowers its customers in their pursuit of revolutionary technology solutions. The company designs, develops and manufactures critical medical device technologies for the cardiac, neuromodulation, vascular and orthopaedic markets, and power management solutions for high-end niche applications in the portable medical, energy, environmental and military markets.
Greatbatch Extends Its Relationship with WiTricity to Include Wireless Energy Transfer for Implantable and Interventional Medical Devices. Greatbatch Announces Completion of Nuvectra Spin-Off. Aleva Neurotherapeutics and Greatbatch Collaborate on Next-Generation Device for Deep Brain Stimulation (DBS). Greatbatch Awarded $37.5 Million in Patent Infringement Lawsuit Against AVX Corporation. Greatbatch Receives FDA Approval of Algovita(R) Spinal Cord Stimulation System. Greatbatch, Inc. Completes Acquisition of Lake Region Medical. Greatbatch Partners with Wireless Power Leader WiTricity to Provide Wireless Charging for Medical Devices. Algostim, LLC to be Renamed Nuvectra.
|Key Personnel: Joseph Dziedzic, president & CEO; Jeremy Friedman, EVP & COO; Gary Haire, EVP & CFO; Joseph Flanagan, EVP, quality & regulatory affairs; Declan Smyth, president, adv. surgical & orthopedics; Tony Gonzalez, president, CRM & neuromod; John Harris, interim president, Cardio & Vascular; Jennifer Bolt, president, electrochem; Timothy McEvoy, SVP, GC, secretary; Michael Spencer, SVP, chief ethics & compliance officer; Tony Borowicz, VP, strategy & biz dev; Kirsten Mickesh, interim chief HR officer;|
2591 Dallas Parkway